181 related articles for article (PubMed ID: 24893155)
1. Integrating emerging treatment options in mantle cell lymphoma.
Kahl BS; Fowler NH; Czuczman MS
Clin Adv Hematol Oncol; 2013 Dec; 11(12 Suppl 19):1-15. PubMed ID: 24893155
[TBL] [Abstract][Full Text] [Related]
2. Unmet needs in the treatment of mantle cell lymphoma.
Rosen ST; Link BK; Fowler NH
Clin Adv Hematol Oncol; 2013 Nov; 11(11 Suppl 18):1-19. PubMed ID: 24893041
[TBL] [Abstract][Full Text] [Related]
3. Treatment strategies in mantle cell lymphoma.
Maddocks K; Blum KA
Cancer Treat Res; 2015; 165():251-70. PubMed ID: 25655613
[TBL] [Abstract][Full Text] [Related]
4. Current regimens and novel agents for mantle cell lymphoma.
Chen Y; Wang M; Romaguera J
Br J Haematol; 2014 Oct; 167(1):3-18. PubMed ID: 24974852
[TBL] [Abstract][Full Text] [Related]
5. Should there be a standard therapy for mantle cell lymphoma?
Smith MR
Future Oncol; 2011 Feb; 7(2):227-37. PubMed ID: 21345142
[TBL] [Abstract][Full Text] [Related]
6. The emerging role of lenalidomide in the management of mantle cell lymphoma (MCL).
Dawar R; Hernandez-Ilizaliturri F
Best Pract Res Clin Haematol; 2012 Jun; 25(2):185-90. PubMed ID: 22687454
[TBL] [Abstract][Full Text] [Related]
7. [Current treatment strategy in mantle cell lymphoma].
Ogura M
Nihon Rinsho; 2014 Mar; 72(3):499-511. PubMed ID: 24724411
[TBL] [Abstract][Full Text] [Related]
8. [Mantle Cell Lymphoma - Cutting edge Dia-gnostics and Treatment Approaches].
Klener P; Trněný M
Klin Onkol; 2015; 28 Suppl 3():3S80-6. PubMed ID: 26489506
[TBL] [Abstract][Full Text] [Related]
9. Mantle cell lymphoma: 2012 update on diagnosis, risk-stratification, and clinical management.
Vose JM
Am J Hematol; 2012 Jun; 87(6):604-9. PubMed ID: 22615102
[TBL] [Abstract][Full Text] [Related]
10. [Mantle cell lymphoma: Towards a personalized therapeutic strategy?].
Navarro Matilla B; García-Marco JA
Med Clin (Barc); 2015 Jun; 144(12):553-9. PubMed ID: 25023849
[TBL] [Abstract][Full Text] [Related]
11. Mantle cell lymphoma: 2013 Update on diagnosis, risk-stratification, and clinical management.
Vose JM
Am J Hematol; 2013 Dec; 88(12):1082-8. PubMed ID: 24273091
[TBL] [Abstract][Full Text] [Related]
12. Management of relapsed mantle cell lymphoma: still a treatment challenge.
Ruan J; Coleman M; Leonard JP
Oncology (Williston Park); 2009 Jul; 23(8):683-90. PubMed ID: 19711582
[TBL] [Abstract][Full Text] [Related]
13. Mantle cell lymphoma: established therapeutic options and future directions.
Lenz G; Dreyling M; Hiddemann W
Ann Hematol; 2004 Feb; 83(2):71-7. PubMed ID: 14669040
[TBL] [Abstract][Full Text] [Related]
14. Therapy of mantle cell lymphoma: current standards and future strategies.
Schmidt C; Dreyling M
Hematol Oncol Clin North Am; 2008 Oct; 22(5):953-63, ix. PubMed ID: 18954745
[TBL] [Abstract][Full Text] [Related]
15. [Treatment for mantle cell lymphoma].
Izutsu K
Rinsho Ketsueki; 2017; 58(10):2026-2032. PubMed ID: 28978845
[TBL] [Abstract][Full Text] [Related]
16. Treatment options for mantle cell lymphoma.
Smolewski P; Witkowska M; Robak T
Expert Opin Pharmacother; 2015; 16(16):2497-507. PubMed ID: 26360791
[TBL] [Abstract][Full Text] [Related]
17. Diagnosis and management of lymphoma.
Abbott BL
Clin Lymphoma Myeloma; 2006 Jul; 7(1):30-2. PubMed ID: 16879767
[TBL] [Abstract][Full Text] [Related]
18. Treatment of mantle cell lymphoma: current approach and future directions.
Brody J; Advani R
Crit Rev Oncol Hematol; 2006 Jun; 58(3):257-65. PubMed ID: 16751087
[TBL] [Abstract][Full Text] [Related]
19. [Salvage therapy in relapsed or refractory malignant lymphoma].
Kashimura T; Murohashi I
Nihon Rinsho; 2000 Mar; 58(3):699-703. PubMed ID: 10741149
[TBL] [Abstract][Full Text] [Related]
20. [Current therapeutic strategies for mantle cell lymphoma].
Dreyling M; Schnaiter A; Schmidt C; Hoster E
Internist (Berl); 2016 Mar; 57(3):230-7. PubMed ID: 26886710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]